Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of MRI in Assessment of Primary Tumor During Chemoradiation for Anal Canal and Perianal Cancer

NCT01053923 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01053923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01053923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of MRI in Assessment of Primary Tumor During Chemoradiation for Anal Canal and Perianal Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Withdrawn
Start date
December 31, 2009
Completion date
March 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer patients, perianal patients